首页> 外文期刊>British Journal of Cancer >Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
【24h】

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

机译:基于线摄影术的晚期食管胃腺癌一线化疗患者生存预测:曲妥珠单抗时代的多中心前瞻性研究

获取原文
获取外文期刊封面目录资料

摘要

Background:To develop and validate a nomogram and web-based calculator to predict overall survival (OS) in Caucasian-advanced oesophagogastric adenocarcinoma (AOA) patients undergoing first-line combination chemotherapy.
机译:背景:开发并验证基于诺模图和基于网络的计算器,以预测接受一线联合化疗的高加索高级食管胃腺癌(AOA)患者的总生存期(OS)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号